Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Liabilities and Shareholders Equity: 2009-2024

Historic Liabilities and Shareholders Equity for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $36.1 billion.

  • Fresenius Medical Care AG's Liabilities and Shareholders Equity rose 113.32% to $36.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $141.8 billion, marking a year-over-year decrease of 286.46%. This contributed to the annual value of $36.3 billion for FY2024, which is 48.22% down from last year.
  • Per Fresenius Medical Care AG's latest filing, its Liabilities and Shareholders Equity stood at $36.1 billion for Q3 2025, which was up 113.32% from $35.4 billion recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Liabilities and Shareholders Equity registered a high of $40.0 billion during Q1 2021, and its lowest value of $58.0 million during Q4 2021.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $37.3 billion (2024), whereas its average is $35.5 billion.
  • In the last 5 years, Fresenius Medical Care AG's Liabilities and Shareholders Equity plummeted by 7420.66% in 2021 and then soared by 6281995.2% in 2022.
  • Fresenius Medical Care AG's Liabilities and Shareholders Equity (Quarter) stood at $58.0 million in 2021, then soared by 62819.95% to $36.5 billion in 2022, then rose by 0.08% to $36.5 billion in 2023, then dropped by 1.75% to $35.9 billion in 2024, then rose by 0.67% to $36.1 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $36.1 billion for Q3 2025, versus $35.4 billion for Q2 2025 and $34.4 billion for Q1 2025.